Nutex Health (NUTX)
(Delayed Data from NSDQ)
$10.10 USD
+2.20 (27.85%)
Updated Aug 9, 2024 03:59 PM ET
After-Market: $9.95 -0.15 (-1.48%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
NUTX 10.10 +2.20(27.85%)
Will NUTX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for NUTX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for NUTX
InnovAge Holding Corp. (INNV) Reports Q1 Loss, Tops Revenue Estimates
Nutex Health Inc. (NUTX) Reports Q2 Loss, Lags Revenue Estimates
NUTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Enhabit (EHAB) Lags Q2 Earnings and Revenue Estimates
Agiliti (AGTI) Q2 Earnings Lag Estimates
Pediatrix Medical Group (MD) Meets Q2 Earnings Estimates
Other News for NUTX
Nutex Health (NUTX) Q2 2024 Earnings Call Transcript
NUTX Stock Earnings: Nutex Health Misses EPS, Beats Revenue for Q2 2024
Nutex Health GAAP EPS of -$0.07, revenue of $76.1M
NUTEX HEALTH REPORTS SECOND QUARTER AND SIX MONTHS ENDED JUNE 30, 2024 FINANCIAL RESULTS
NUTEX HEALTH SCHEDULES 2024 SECOND QUARTER FINANCIAL RESULTS RELEASE AND CONFERENCE CALL